UKGI’s corporate finance team has worked closely with HMG’s Vaccine Task Force (the VTF) since its inception in April 2020. A small number of UKGI employees worked intensively with the VTF over the year to secure access to a portfolio of vaccines, and are
credited with a strong contribution to its success.
UKGI employees, working together with BEIS as one team, led the negotiations for all seven of the initial vaccines purchased by HMG to tackle COVID-19 and also helped to secure vaccine and fill/finish manufacturing capacity, build capability and secure additional doses of vaccines.
UKGI influence has extended to the current VTF Director General being recruited from its ranks. UKGI continues to be involved in this area in particular in relation to expanding the UK’s vaccine manufacturing capability.